Colorectal serrated lesions and polyps in the Danish population: A large nationwide register-based cohort study

Abstract

Background and study aims Colorectal serrated lesions and polyps (SPs) include hyperplastic polyps (HP), sessile serrated lesions-/+dysplasia (SSL/SSL-D), and traditional serrated adenomas (TSA). From 20% to 30% of colorectal cancers (CRC) develop from SP. We present incidence and baseline characteristics of SP in a Danish cohort.

Patients and methods We used The Danish Pathology Registry to include all SPs in the Danish population from January 1, 2000 to December 31, 2021. Based on the unique Danish personal identification number and SNOMED-codes, combined with the age and sex of patients, and date of procedure, we determined the incidence of the SP subtypes, anatomical location, and changes over time.

Results During the period from 2000 to 2021, a total of 292,761 SPs were removed from 163,840 patients: 51,649 SSLs, 5959 SSL-Ds, 224,860 HDs, and 10,293 TSAs. The median age of patients was 64.1 years (range 55.2–71.6) and 53.3% were male. We found a general increase in SPs from 3525 in 2000 to 25,853 in 2021 and a rise in the SSL proportion from 1.7% in 2006 to 38% in 2021. Half of all patients had more than one lesion at endoscopy with conventional adenomas being the most common. CRC was found along with SPs in 3.3% of procedures, while 1% to 2.5% of the patients developed metachronous CRC.

Conclusions We found an increasing number of SPs, especially SSLs. From 2019 to 2021 the number of SPs seem to stabilize, while the proportion of SSLs keeps rising. Synchronous lesions were common along all subtypes of SP.

Keywords

Colorectal cancer - CRC screening - GI Pathology - Epidemiology

Publikationsverlauf

Eingereicht: 24. Mai 2023

Angenommen nach Revision: 06. November 2023

Artikel online veröffentlicht:
12. Dezember 2023

• References

• 1 Bray F, Ferlay J, Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424
• 2 Danish Colorectal Cancer Group(DCCG). DCCG årsrapport 2021 [DCCG annual report 2021] (October 2022). Zugriff am 01. Januar 2000 unter: https://dccg.dk/wp-content/uploads/2023/07/DCCG-Aarsrapport-2021-offentliggjort-version-20221003.pdf
• 3 Crockett SD, Nagtegaal ID. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia. Gastroenterology 2019; 157: 949-966.e4
• 4 Hassan C, Antonelli G, Dumonceau J-M. et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020. Endoscopy 2020; 52: 687-700
• 5 Rutter MD, East J, Rees CJ. et al. British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 2020; 69: 201-223
• 6 Anderson JC, Srivastava A. Colorectal cancer screening for the serrated pathway. Gastrointest Endosc Clin N Am 2020; 30: 457-478
• 7 World Health Organization. Classification of tumours of the digestive tract. 5th ed. Lyon: IARC Press; 2019
• 8 Rex DK, Ahnen DJ, Baron JA. et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012; 107: 1315-1329
• 9 Pai RK, Bettington M, Srivastava A. et al. An update on the morphology and molecular pathology of serrated colorectal polyps and associated carcinomas. Mod Pathol 2019; 32: 1390-1415
• 10 Erichsen R, Baron JA, Hamilton-Dutoit SJ. et al. Increased risk of colorectal cancer development among patients with serrated polyps. Gastroenterology 2016; 150: 895-902.e5
• 11 Song M, Emilsson L, Bozorg SR. et al. Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study. Lancet Gastroenterol Hepatol 2020; 5: 537-547
• 12 IJspeert JEG, Bevan R, Senore C. et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview. Gut 2017; 66: 1225-1232
• 13 Bateman AC. The spectrum of serrated colorectal lesions—new entities and unanswered questions. Histopathology 2021; 78: 780-790
• 14 IJspeert JEG, Bastiaansen BAJ, van Leerdam ME. et al. Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps. Gut 2016; 65: 963-970
• 15 Hewett DG, Kaltenbach T, Sano Y. et al. Validation of a Simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology 2012; 143: 599-607.e1
• 16 Bettington M, Brown I, Rosty C. et al. Sessile serrated adenomas in young patients may have limited risk of malignant progression. J Clin Gastroenterol 2019; 53: e113-e116
• 17 Bettington M, Walker N, Rosty C. et al. Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma. Gut 2017; 66: 97-106
• 18 Lash RH, Genta RM, Schuler CM. Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol 2010; 63: 681-686
• 19 Patobank. Kodebog for patologisk-anatomiske undersøgelser 3rd edition [Codebook for patoanatomical examination] (1996). Zugriff am 01. Januar 2000 unter: https://www.patobank.dk/wp-content/uploads/2019/10/A._Introduktion_og_vejledning_til_SNOMED-2.pdf
• 20 R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Zugriff am 01. Januar 2000 unter: https://www.R-project.org/ version 4.2.0
• 21 Fenoglio-Preiser CM. When is a hyperplastic polyp not a hyperplastic polyp?. Am J Surg Pathol 1999; 23: 1001
• 22 Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas: a distinct form of colorectal neoplasia. Am J Surg Pathol 1990; 14: 524-537
• 23 Torlakovic E, Snover D. Serrated adenomatous polyposis in humans. Gastroenterology 1996; 110: 748-755
• 24 Jass JR. Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer. Am J Clin Pathol 2003; 119: 773-775
• 25 Torlakovic E, Skovlund E, Snover DC. et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 2003; 27: 65-81
• 26 Ahadi M, Sokolova A, Brown I. et al. The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology (Phila) 2021; 53: 454-461
• 27 Aaltonen LA, Hamilton SR. World Health Organization . et al. Pathology and genetics of tumours of the digestive system. Lyon,Oxford: IARC Press; Oxford University Press; 2000
• 28 Bosman FT. World Health Organization, International Agency for Research on Cancer. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: International Agency for Research on Cancer; 2010
• 29 Nagtegaal ID, Snover DC. Head to head: should we adopt the term ‘sessile serrated lesion’?. Histopathology 2022; 80: 1019-1025
• 30 Lall V, Ismail AGM, Ayonrinde OT. Disparate age and sex distribution of sessile serrated lesions and conventional adenomas in an outpatient colonoscopy population-implications for colorectal cancer screening?. Int J Colorectal Dis 2022; 37: 1569-1579
• 31 Schramm C, Janhsen K, Hofer J-H. et al. Detection of clinically relevant serrated polyps during screening colonoscopy: results from seven cooperating centers within the German colorectal screening program. Endoscopy 2018; 50: 993-1000
• 32 Carr NJ, Mahajan H, Tan KL. et al. Serrated and non-serrated polyps of the colorectum: their prevalence in n unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 2009; 62: 516-518
• 33 Njor SH, Friis-Hansen L, Andersen B. et al. Three years of colorectal cancer screening in Denmark. Cancer Epidemiol 2018; 57: 39-44
• 34 Sonnenberg A, Genta RM. Synchronous occurrence of different polyp types during colonoscopy. Aliment Pharmacol Ther 2022; 56: 777-782
• 35 Abdeljawad K, Vemulapalli KC, Kahi CJ. et al. Sessile serrated polyp prevalence determined by a colonoscopist with a high lesion detection rate and an experienced pathologist. Gastrointest Endosc 2015; 81: 517-524